ImmunoSensation - the immune sensory system

Chirurg . 2020 Jun 2.

[Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients]

Vittorio Branchi, Tobias J Weismüller, Taotao Zhou, Jonas Henn, Alexander Semaan, Tim R Glowka, Maria Gonzalez-Carmona, Christian Strassburg, Jörg C Kalff, Steffen Manekeller, Hanno Matthaei

Background: In recent years substantial progress has been made in the treatment, surveillance and understanding of the pathogenesis of primary sclerosing cholangitis (PSC); however, in most cases liver transplantation (LTX) is still the only curative option for cancer or end-stage liver disease (ELD). In rare cases a partial liver resection is a possible curative treatment of a PSC-associated cholangiocellular carcinoma (CCC). These operations represent a significant additional burden for PSC patients.

PMID: 32488382